30-Oct-2026 15:21:57
ALKEM : US FDA INSPECTION AT MANDVA API FACILITY ENDS WITH NO FORM 483 OBSERVATIONS
Inspection conducted from 26th October 2026 to 30th October 2026 at the company's API manufacturing facility at Mandva.
Latest market headlines for ALKEM on Terminal.
30-Oct-2026 15:21:57
Inspection conducted from 26th October 2026 to 30th October 2026 at the company's API manufacturing facility at Mandva.
21-Oct-2026 21:48:56
• Audit Committee approved forensic audit on 21 October 2026 into alleged misappropriation of funds by a former employee • Grant Thornton Bharat LLP appointed…
12-Oct-2026 15:43:54
Mr. Laxmikant Tiwari (27+ years in pharma operations, MBA Operations, B.Pharm) and Mr. Nilesh Vartak (24+ years in supply chain across pharma/healthcare and co…
16-Sept-2026 11:42:57
• Alkem Laboratories announced the launch of NeuCeno (cenobamate), an anti-seizure medication for partial-onset seizures in adult patients. • NeuCeno is a once…
08-Sept-2026 15:09:15
• Alkem Laboratories Limited announces the launch of Renocia Exo™, a next-generation hair regeneration therapy. • The serum is India's first patented Ginsenosi…
17-Jul-2026 18:08:43
• Alkem Medtech Private Limited, a wholly owned subsidiary of the Company in India, has completed the acquisition of at least 51% and up to 55% of the total is…
16-Jul-2026 14:59:14
• Alkem Medtech Private Limited, a wholly owned subsidiary, acquired rights shares in Occlutech Holding AG. • The acquisition aims for 51% to 55% of Occlutech'…
29-Jun-2026 09:34:58
• Alkem Medtech Private Limited, a wholly owned subsidiary, intends to acquire at least 51% and up to 55% of Occlutech Holding AG. • This is in continuation of…